BCIS ACI 2020: TAVI Should Now Be the Default Treatment for Patients with Symptomatic Aortic Stenosis

Published: 13 March 2020

  • Views:

    Views Icon 379

  • Likes:

    Heart Icon 7
  • episode_image
    Now Playing
    Part 2
    Pro Argument
    David Hildick-Smith
    Up Next
  • episode_image
    6m 45s
    Part 4 Panel Discussion
    Clare Appleby, Simon Redwood, Gregg Stone, Andrew SP Sharp, Rob Butler, Marjan Jahangiri
Average (ratings)
No ratings
Your rating

Overview

In this video series chairs, Prof Simon Redwood (Guy’s and St Thomas’ NHS Foundation Trust, London, UK) and Dr Clare Appleby (Liverpool Heart and Chest Hospital, Liverpool, UK) ask the question “Should TAVI be the default treatment for patients with symptomatic aortic stenosis?". From BCIS ACI’s audience and introducing the panel of the debate. Further through the series Prof David Hildick-Smith (Sussex Cardiac Centre, Brighton, UK) argues for an interventional approach whilst Prof Marjan Jahangiri (St George's University Hospitals NHS Foundation Trust, London, UK) argues that surgery, SAVR should be considered based on life expectancy in the treatment of patients with symptomatic aortic stenosis. The series concludes with the panel and chairs reflecting on the data and recent arguments delivered. 

This content was provided by the courtesy of BCIS.

More from this programme

Part 1

Introduction and preliminary poll

Chairs, Prof Simon Redwood (Guy’s and St Thomas’ NHS Foundation Trust, London, UK) and Dr Clare Appleby (Liverpool Heart and Chest Hospital, Liverpool, UK) ask the question “Should TAVI be the default treatment for patients with symptomatic aortic stenosis?". From BCIS ACI’s audience and introducing the panel of the debate.
1 session
Introduction and preliminary poll Watch now

Part 2

Pro Argument

Prof David Hildick-Smith (Sussex Cardiac Centre, Brighton, UK) argues for an interventional approach in the treatment of patients with symptomatic aortic stenosis.
1 session
Pro Argument Watch now

Part 3

Contra Argument

Prof Marjan Jahangiri (St George's University Hospitals NHS Foundation Trust, London, UK) argues that surgery, SAVR should be considered based on life expectancy in the treatment of patients with symptomatic aortic stenosis.
1 session
Contra Argument Watch now

Part 4

Panel Discussion

The panel and the chairs conclude the debate by reflecting on recent data and the arguments delivered by Prof Marjan Jahangiri (St George's University Hospitals NHS Foundation Trust, London, UK) and Prof David Hildick-Smith (Sussex Cardiac Centre, Brighton, UK).
1 session
Panel Discussion Watch now

Faculty Biographies

David Hildick-Smith

David Hildick-Smith

Prof David Hildick-Smith is Professor of Interventional Cardiology and Consultant Cardiologist at the Sussex Cardiac Centre - the Regional Specialist Unit. He is Director of the Cardiac Research, ex-Treasurer of the British Cardiovascular Interventions Society, and, with more than 20 years experience of Interventional Cardiology, is considered one of the country's leading experts in management of Cardiovascular complaints.

A pioneer of Interventional Cardiology, David is recognised internationally as a leader in cardiovascular diagnosis and treatment. 

View full profile